Европейски съюз - български - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - ХИВ инфекции - Антивирусни средства за системно приложение - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Европейски съюз - български - EMA (European Medicines Agency)

viiv healthcare b.v. - fostemsavir trometamol - ХИВ инфекции - Антивирусни средства за системно приложение - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Европейски съюз - български - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - Имунни серуми и имуноглобулини - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Европейски съюз - български - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegravir - ХИВ инфекции - Антивирусни средства за системно приложение - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 и 5.